Thank you, Mr. Chair.
Thank you very much for appearing. I've been looking forward to the opportunity to speak with you and hear a bit about the negotiations.
I want to start with a couple of things. I was reviewing your testimony before the committee in November. You stated that no analysis had been done by the department with respect to the potential additional costs to the health care system of the extension of patent protection under intellectual property. I'd like to know if that's still the case or whether something has been done.
There has been some work done by other groups about what the potential impact will be on our health care system. I'm hoping you have a handle on that.